2025
SJR Q1
JCR Q1 · 7,2
20 matched articles
SCIE
Journal detail
Current Molecular Pharmacology
- Publisher
- KeAi Communications Co.
- Country
- United Arab Emirates · Middle East
- Type
- journal
- ISSN
-
1874467218744702
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,024
- Quartile Q1
- H-Index 54
- Cites/doc 5,53
- Docs (3y) 257
- Cites (3y) 1.277
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 7,2
- 5Y JIF 5
- JCI 0,97
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Drug Discovery Q1
- Molecular Medicine Q2
- Pharmacology Q1
Areas
- Biochemistry, Genetics and Molecular Biology
- Pharmacology, Toxicology and Pharmaceutics
WoS categories
- Biochemistry & Molecular Biology | Pharmacology & Pharmacy
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,024 | 7,2 | 5 | 0,97 | Q1 | 54 |
| 2024 | Q2 | Q2 | 0,653 | 2,9 | 3,1 | 0,56 | Q3 | 52 |
| 2023 | Q3 | Q3 | 0,54 | 2,4 | 2,8 | 0,52 | Q3 | 52 |
| 2022 | Q2 | Q3 | 0,694 | 2,7 | 3,2 | 0,55 | Q3 | 52 |
| 2021 | Q2 | Q2 | 0,729 | 3,9 | 3,4 | 0,55 | Q3 | 52 |
| 2020 | Q2 | Q3 | 0,717 | 3,3 | 3 | 0,57 | Q3 | 52 |
| 2019 | Q2 | Q2 | 0,629 | 3,3 | — | 0,56 | Q3 | 52 |
| 2018 | — | Q4 | — | 1,6 | — | 0,59 | Q3 | — |
| 2017 | Q1 | Q3 | 0,996 | 2,5 | — | 0,7 | Q2 | 52 |
| 2016 | Q1 | — | 1,09 | — | — | — | — | 52 |
| 2015 | Q1 | — | 1,354 | — | — | — | — | 52 |
| 2014 | Q1 | — | 1,419 | — | — | — | — | 52 |
| 2013 | Q1 | — | 1,455 | — | — | — | — | 52 |
| 2012 | Q1 | — | 1,56 | — | — | — | — | 52 |
| 2011 | Q1 | — | 1,689 | — | — | — | — | 52 |
| 2010 | Q2 | — | 0,69 | — | — | — | — | 52 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | Q1 | 46/328 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q1 | Q1 | 32/356 |
| 2024 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 182/320 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 150/352 |
| 2023 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 222/313 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 188/354 |
| 2022 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | Q3 | 214/285 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 177/278 |
| 2021 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 172/297 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 124/279 |
| 2020 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q3 | 185/295 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 145/276 |
| 2019 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q2 | Q3 | 139/297 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 94/271 |
| 2018 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | Q3 | 254/299 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | Q3 | 211/267 |
| 2017 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q3 | Q2 | 176/293 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 131/261 |